Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease

NCT05047523 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

40

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision to terminate the program

Conditions

Wilson Disease

Interventions

DRUG: ALXN1840
DRUG: Standard of Care

Sponsor

Alexion Pharmaceuticals, Inc.